SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 194 filers reported holding SEATTLE GENETICS INC in Q2 2014. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$56,000
+154.5%
286
+116.7%
0.03%
+141.7%
Q2 2020$22,000
+633.3%
132
+428.0%
0.01%
+500.0%
Q1 2020$3,0000.0%250.0%0.00%
+100.0%
Q4 2019$3,000
+50.0%
250.0%0.00%0.0%
Q3 2019$2,0000.0%250.0%0.00%0.0%
Q2 2019$2,0000.0%250.0%0.00%0.0%
Q1 2019$2,000
+100.0%
250.0%0.00%
Q4 2018$1,000
-99.9%
25
-99.9%
0.00%
-100.0%
Q1 2014$1,367,000
+14.2%
30,0000.0%0.44%
+5.8%
Q4 2013$1,197,000
-9.0%
30,0000.0%0.41%
-16.5%
Q3 2013$1,315,000
+39.3%
30,0000.0%0.50%
+45.9%
Q2 2013$944,00030,0000.34%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders